The Cancer Consortium

Cancer News & Information Center

Saturday, October 31st, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

High Hopes for New Prostate-Cancer Test

By Global Cancer Consortium on April 26, 2007 • ( Leave a comment )

Results released today from a study of a new test for prostate cancer have raised spirits in the medical community and at the private Seattle firm that discovered it. Onconome‘s blood test measures […]

Biomoda Hopes Marketing Will Boost Licensing and Sales

By Global Cancer Consortium on April 17, 2007 • ( Leave a comment )

Biomoda, an Albuquerque, NM, maker of cancer diagnostics, announced today that it has hired Synergestic Marketing to help “accelerate licensing development and sales relationships with customers domestically and worldwide,” according to Biomoda’s president, […]

NeoGenomics and Power3 Form CRO

By Global Cancer Consortium on April 6, 2007 • ( Leave a comment )

NeoGenomics, a Fort Meyers, FL-based lab that specializes in cancer diagnostic testing, announced on Wednesday that it was teaming up with protein biomarker maker Power3 Medical Products to form a joint venture […]

Three Device Makers Field IPOs

By Global Cancer Consortium on April 5, 2007 • ( Leave a comment )

Three venture-backed medical device firms raised more than $400 million through IPOs last quarter, Red Herring reports. Topping the list of money makers was Sunnyvale, CA-based Accuray, maker of the CyberKnife Robotic […]

North American Scientific Poaches Sanarus Chief

By Global Cancer Consortium on March 23, 2007 • ( Leave a comment )

Chatsworth, CA-based North American Scientific announced yesterday the appointment of John Rush as president and CEO. The med tech company, which makes radioisotope products for the treatment of cancer, lured Rush from Sanarus Medical of Pleasanton, […]

Posts navigation

‹ Newer 1 … 79 80 81 82 83 84

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.